OnCo

No description yet: the sentence for this tag has not been written. 2 records carry it: 2 people.

2 records
Andreas Engert
Professor of Internal Medicine, Hematology and Oncology, University Hospital Cologne; former Chair, German Hodgkin Study Group · Uniklinik Köln (CIO)
Led the GHSG for two decades, running the HD10 to HD18 trials that cure over 90% of Hodgkin lymphoma with less treatment.
Peter Borchmann
Professor of Medicine and Head of the German Hodgkin Study Group, University Hospital Cologne · Uniklinik Köln (CIO)
Leads the German Hodgkin Study Group and HD21, which made BrECADD the most effective and least toxic regimen for advanced Hodgkin lymphoma.

This tag as JSON · API